It serves as a synthetic intermediate or reagent in pharmaceutical research particularly for developing androgen receptor antagonists and c-Met kinase inhibitors via derivatization.

Its primary purpose is to provide a functionalized benzamide scaffold for structure-activity relationship studies in medicinal chemistry targeting hormone receptors and tyrosine kinases.

4-Amino-2-fluoro-N-methylbenzamide (CHFNO) is a white to off-white solid aromatic amide with a benzene ring substituted by an amino group at position 4 fluorine at 2 and an N-methylcarboxamide at 1 molecular weight 168.17 gmol melting point 160163C.